HopeStage
Back to all studies
CompletedNCT00794040

Citalopram added to methylphenidate for severe irritability in youth

About this titleRead the official source — NCT00794040
Medication studyAges 7–17United StatesADHD
The study in practice

Understand this study

Who was this study for?

Listed age limits: 7 years to 17 years.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNovember 17, 2008
Recruitment status
Completed
Enrollment listed in the registry
103
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 7 Years to 17 Years
Official registry ID
NCT00794040
Official title
Show the full official title

A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Add-on citalopram following optimized methylphenidate and Add-on placebo following optimized methylphenidate.

Who was this study for?

Listed age limits: 7 years to 17 years.

Want to explore more studies?

Explore studies